WHO Pharmaceuticals Newsletter 1998, No. 03&04
(1998; 18 pages)
Índice de contenido
Abrir esta carpeta y ver su contenidoRegulatory actions
Abrir esta carpeta y ver su contenidoDrug surveillance
Abrir esta carpeta y ver su contenidoNew developments
Ver el documentoRecent approvals
Abrir esta carpeta y ver su contenidoMedical devices
Cerrar esta carpetaGeneral information
Ver el documentoAdvertising of medicinal drugs in the media - regulations
Ver el documentoContainer and closure testing in lieu of sterility testing - draft guidance available
Ver el documentoExtended release oral dosage forms - draft guidance available
Ver el documentoHuman plasma-derived biological products or animal plasma or serum-derived products - draft guidance available
Ver el documentoIron-containing supplements and drugs - small entity compliance guidance available
Ver el documentoMedication errors - the "look-alike/sound alike" problem: name confusion
Ver el documentoMedication errors: esmolol - another fatal case
Abrir esta carpeta y ver su contenidoVeterinary medicine
 

Medication errors - the "look-alike/sound alike" problem: name confusion

UK, United States of America. LamictalR and LamisilR. The Committee on Safety of Medicines has drawn attention to the similarity in spelling and pronunciation of the anti-epileptic LamictalR (lamotrigine) and the antifungal agent LamisilR (terbinafine). Recent reports show that a small number of patients have been prescribed or have received the wrong drug.

Prescribing with the generic name will avoid confusion.

PilocarR and DilacorXRR. A pharmacist received an order that looked like "Resume PilocarR [pilocarpine ophthalmic solution] as at home". When he called to find out which concentration was needed, he learned that the prescription should have been "Resume Dilacor XRR" [diltiazem]. The error was avoided in this case, but it is another example of confusion due the name similarities, even when the drugs have widely divergent dosage forms, doses and uses.

References:

1) Current Problems in Pharmacovigilance Vol. 23, December 1997.

2) ISMP Medication Safety Alert!, 30 July 1997.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013